Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
2021
Europe
Clear all
Type of publications
NITAG documentation
(74)
Systematic reviews (SYSVAC)
(3)
Topics
Available to download in languages
Regions
Europe
(77)
Africa
(19)
Americas
(68)
South-East Asia
(3)
Western Pacific
(15)
Countries
Belgium
(15)
Denmark
(1)
France
(17)
Germany
(8)
Ireland
(7)
Netherlands
(6)
Spain
(1)
Sweden
(2)
United Kingdom
(19)
Diseases
COVID-19
(76)
Human papillomavirus (HPV)
(1)
Hepatitis B
(1)
Influenza
(4)
Pneumococcal disease
(1)
Rotavirus
(1)
Varicella
(1)
Vaccine topics
Acceptance
(2)
Coverage
(3)
Ethical issues
(1)
Target population
Adolescents
(1)
Adults
(2)
All age groups
(2)
Healthcare workers
(1)
Older adults
(1)
Pregnant women
(1)
Risk group
(2)
Publication date
2021
(77)
2024
(2)
2023
(15)
2022
(38)
2020
(21)
2019
(9)
2018
(7)
2017
(14)
2016
(4)
2015
(7)
2014
(7)
2013
(4)
2012
(1)
2011
(2)
2010
(5)
2009
(2)
2008
(2)
2007
(3)
2004
(1)
2001
(1)
77 results found
2021
∙
JCVI
JCVI advice on the UK vaccine response to the Omicron variant
2021
∙
JCVI
JCVI advice on Third primary COVID-19 vaccine dose for people who are immunosuppressed - 1 September, 2021
2021
∙
JCVI
JCVI advice to mitigate impact of B1.617.2 variant - 14 May 2021
2021
∙
JCVI
JCVI advises on the use of the coronavirus (COVID-19) Oxford/AstraZeneca vaccine for people aged under 40 - 7 May 2021
2021
∙
JCVI
JCVI final statement on phase 2 of the COVID-19 vaccination programme: 13 April, 2021
2021
∙
JCVI
JCVI interim advice: potential COVID-19 booster vaccine programme winter 2021 to 2022 - 30 June 2021
2021
∙
JCVI, Public Health England
JCVI interim statement on phase 2 of the COVID-19 vaccination programme
2021
∙
JCVI
JCVI issues new advice on COVID-19 vaccination for pregnant women - 16 April, 2021
2021
∙
JCVI
JCVI issues updated advice on COVID-19 booster vaccination - 14 September 2021
2021
∙
JCVI
JCVI issues updated advice on COVID-19 vaccination of children aged 12 to 15 - 3 September, 2021
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register